CME earnings — 2026-07-22

Reported the quarter ending 2026-06-30: revenue $1.71B, diluted EPS $2.88, net income $1.04B (SEC filing). Across the print the stock moved +7.1% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

Sources

• Financials: edgar
• Price reaction: ohlc